SUMMARY An enzyme linked immunosorbent assay (ELISA) for detecting antibodies against cytomegalovirus induced immediate early antigens and early antigens was developed using purified nuclear antigens and was compared with the indirect immunofluorescence test. The tests were comparable in their ability to dectect positive and negative sera, and antibody titres determined by both assays were similar. The use of ELISA for the detection of antibodies against cytomegalovirus induced immediate early and early antigens is advocated in diagnostic and research laboratories.
Human cytomegalovirus (CMV) can cause serious illnesses including congenital malformations, mononucleosis syndrome following blood transfusions, and serious, sometimes fatal, complications in organ allograft recipients. The wide range of CMV infections emphasises the need for diagnostic techniques capable of rapid and reliable detection of active CMV infection.
In cells infected by human CMV several antigens appear at varying intervals after infection. Before DNA viral replication CMV induces the appearance of immediate early ' and early2 antigens, which are present in the nuclei of infected cells 1 h and 24 h after infection respectively. About 72 h after infection, at the end of the CMV replication cycle, late antigens (LA) are demonstrable in the nucleus and cytoplasm of infected cells.3 It is also known that the immune response to these different antigens has a different incidence and importance. While high concentrations of antibodies to late antigens persist long after the recovery from a CMV active infection, the presence of antibodies against CMV induced immediate early and early antigens has been shown to be associated with an active CMV infection (primary or reactivated) in acutely ill patients, and antibody titres undergo a relatively rapid decrease after the disappearance of symptoms. [4] [5] [6] Accepted for publication 17 October 1983 The presence of antibodies against CMV induced late antigens is normally shown by a complement fixation test7 or immunofluorescence technique;8 moreover, many enzyme linked immunosorbent assays have been developed to assess an immune state against CMV induced late antigens using, as a source of antigen, CMV infected cells fixed at the end of the viral replication cycle.9-" ' The presence of antibodies against immediate early and early antigens, however, has always been shown only by an indirect immunofluorescence test, but the practical value of this assay is partially impaired by the presence of non-specific cytoplasmic IgG receptors in CMV infected cells '2 or by the presence of aspecific antibodies to nuclear components in allograft recipients.
As With these criteria, out of 100 sera negative by immunofluorescence for immediate early antigens 98 proved to be negative by ELISA while two were positive; of 100 sera negative by immunofluorescence for early antigens 96 proved true negative by ELISA while four had values above the positive threshold.
Of the 98 sera negative by immunofluorescence and ELISA for immediate early antigens, the average value was 3*41 with a standard deviation of 1-7; out of the 96 sera negative by immunofluorescence and ELISA for early antigens, the mean value was 4-25 with a standard deviation of 2-7.
A further 10 sera showing aspecific antinuclear antibodies by immunofluorescence were analysed by ELISA for immediate early and early antigens to exclude false positive reactions. These 10 sera proved negative for immediate early and early antigens by ELISA.
To assess the specificity of the ELISA procedure to test antibodies against immediate early and early antigens a total of 116 sera positive by immunofluorescence for immediate early and early antigens were evaluated by ELISA. 
